They exhibit elevated expression of CD16 and NKG2D receptors, which are capable of identifying stress ligands on tumor cells (such as MICA/B) and function synergistically with CD8+ T cells to eradicate immuno-evasive tumor cells. The gene discussed is CD8A; the disease is neoplasm.